Zobrazeno 1 - 10
of 12
pro vyhledávání: '"R W, de Vere White"'
Autor:
R. W. De Vere White, Swagata Bose, Yu Wang, Chong-Xian Pan, Paramita M. Ghosh, Margarita Mikhailova
Publikováno v:
Oncogene. 27:7106-7117
The mTOR (mammalian target of rapamycin) inhibitor rapamycin caused growth arrest in both androgen-dependent and androgen-independent prostate cancer cells; however, long-term treatment induced resistance to the drug. The aim of this study was to inv
Publikováno v:
BJU International. 93:143-150
Three of the studies described in this section relate to bladder cancer. The first of these concerns the PI-3 kinase pathway, which has been a topic of interest in cancer in general. The authors from Sacramento suggest that it may regulate cancer cel
Autor:
Xu-Bao Shi, Regina F Gandour-Edwards, Clifford G. Tepper, R. W. De Vere White, Lingru Xue, Ruth Louise Vinall
Publikováno v:
Oncogene. 25(14)
Mutations in p53 occur at a rate of approximately 70% in hormone-refractory prostate cancer (CaP), suggesting that p53 mutations facilitate the progression of CaP to androgen-independent (AI) growth. We have previously reported that transfection of p
Autor:
Stavros G. Demos, Regina F Gandour-Edwards, R. W. De Vere White, Richard J. Bold, Rajendra Ramsamooj
Publikováno v:
Biomedical Topical Meeting.
We explore NIR autofluorescence and polarized light scattering imaging in combination with hyperspectral microscopy to detect and image various types of cancer . Fresh surgical human specimens are used and images are compared to histopathology
Autor:
Jonathan A. Eandi, Hari S.G.R. Tunuguntla, Christian Bohringer, R. W. De Vere White, Christopher P. Evans
Publikováno v:
Prostate cancer and prostatic diseases. 5(3)
We retrospectively analyzed the analgesic efficacy and surgical outcomes of a single preoperative intrathecal long-acting morphine sulfate injection (0.25-0.5 mg) and postoperative intravenous (i.v.) ketorolac in 62 patients who underwent radical ret
Autor:
R W, de Vere White, E, Stapp
Publikováno v:
Oncology (Williston Park, N.Y.). 12(12)
Bladder cancer is the most common urologic malignancy and is expected to affect approximately 54,000 people in 1998. Superficial bladder tumors (Tis, Ta, and T1 lesions) account for approximately 70% to 80% of these malignancies. Although many advanc
Autor:
M, Nagabhushan, C M, Miller, T P, Pretlow, J M, Giaconia, N L, Edgehouse, S, Schwartz, H J, Kung, R W, de Vere White, P H, Gumerlock, M I, Resnick, S B, Amini, T G, Pretlow
Publikováno v:
Cancer research. 56(13)
Most patients' prostate cancers respond to androgen deprivation but relapse after periods of several months to years. Only two prostate cancer xenografts, LNCaP and PC-346, have been reported to be responsive to androgen deprivation and to relapse su
Publikováno v:
Anticancer research. 13(6A)
In most cases, the appearance of aneuploid peaks in DNA histograms may be an artefact of tissue preparation or it may reflect non-stoichiometric dye binding of a cellular subpopulation rather than true DNA aneuploidy. This report reviews how false DN
Publikováno v:
Cytometry. 14(5)
Autor:
J S, Coon, A D, Deitch, R W, de Vere White, L G, Koss, M R, Melamed, J E, Reeder, R S, Weinstein, R P, Wersto, L L, Wheeless
Publikováno v:
Cancer. 61(1)
Flow cytometric DNA analysis of human urinary bladder specimens may be clinically useful for prognosis in transitional cell (urothelial) carcinoma and for detecting recurrence after treatment. However, many important methodological differences exist